[PDF] International Nonproprietary Names (INN) for pharmaceutical

International Nonproprietary Names for Pharmaceutical Substances

The inclusion of a name in the lists of Recommended International. Nonproprietary Names does not imply any recommendation of the use of the substance in.

International Nonproprietary Names for Pharmaceutical Substances

19 Jan 2018 Recommended International Nonproprietary Names for Pharmaceutical Substances the names given in the list on the following pages are under ...

International Nonproprietary Names for Pharmaceutical Substances

18 Dec 2015 International Nonproprietary Names for Pharmaceutical Substances (INN). Notice is hereby given that in accordance with article 3 of the ...

International Nonproprietary Names (INN) for pharmaceutical

The Programme was established to assign nonproprietary names to pharmaceutical substances so that each substance would be recognized by a unique name. Such 

International Nonproprietary Names for Pharmaceutical Substances

The inclusion of a name in the lists of Recommended. International Nonproprietary Names does not imply any recommendation of the use of the substance in 

International Nonproprietary Names for Pharmaceutical Substances

The inclusion of a name in the lists of Recommended. International Nonproprietary Names does not imply any recommendation of the use of the substance in 

WORLD HEALTH ORGANIZATION International Nonproprietary

17 Apr 2002 In order to select a single nonproprietary name of worldwide acceptability for each active substance used in pharmaceutical preparations

WHO46.19 Nonproprietary Names for Pharmaceutical Substances

Nonproprietary Names for Pharmaceutical Substances. The Forty-sixth World Health Assembly. Recalling resolution WHA31.32 on the importance of using 

International Nonproprietary Names for Pharmaceutical Substances

The inclusion of a name in the lists of Recommended International Nonproprietary Names does not imply any recommendation of the use of the substance in 

WORLD HEALTH ORGANIZATION International Nonproprietary

9 Dec 2004 procedure for the selection of International Nonproprietary Names (INN) for pharmaceutical substances.1 The action plan envisaged further ...

GUIDANCE ON THE USE OF SUBSTANCES - World Health Organization

An International Nonproprietary Name (INN) identifies a pharmaceutical substance or active pharmaceutical ingredient by a unique name that is globally recognized and is public property A nonproprietary name is also known as a generic name The INN system as it exists today was initiated in 1950 by a World Health Assembly resolution

International Nonproprietary Names for Pharmaceutical

Recommended International Nonproprietary Names for Pharmaceutical Substances the names given in the list on the following pages are under consideration by the World Health Organization as Proposed International Nonproprietary Names The inclusion of a name in the lists of Proposed International

Searches related to international nonproprietary names for pharmaceutical substances PDF

afabicina dihidrogenofosfato de {6-[(1E)-3-{metil[(3-metil- 1-benzofuran-2-il)metil]amino}-3-oxoprop-1-en-1-il]-2-oxo- 34-dihidro-18-naftiridin-1(2H)-il}metilo antibiótico C 23H24N3O7P 1518800-35-5 agerafenibum agerafenib N-{3-[(67-dimethoxyquinazolin-4-yl)oxy]phenyl}-N'-[5- (111-trifluoro-2-methylpropan-2-yl)-12-oxazol-3-yl]urea

What is the inn number for nonproprietary names for pharmaceutical substances?

International Nonproprietary Names for Pharmaceutical Substances (INN) WHO Drug Information, Vol. 30, No. 2, 2016 Proposed INN: List 115 241

What is an international nonproprietary name?

Introduction. International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.

What is a nonproprietary drug name?

Many healthcare professionals, particularly pharmacists, know that a drug’s nonproprietary (generic) name can often help position it among other drugs in the same therapeutic class by recognizing drug name stems, a collection of short name fragments, that have been embedded in the nonproprietary drug names.

What is the FDA guidance on nonproprietary naming of biological products?

These concerns led the FDA to create a guidance document for the nonproprietary naming of biological products. 1 The document discusses the need for biological products to possess a nonproprietary name that contains a unique suffix.